References

  1. Siest G, Pillot T, Régis-Bailly A, et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem. 1995; 41(8): 1068-1086. PubMed | Google Scholar

  2. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988; 8 (1): 1-21. PubMed | Google Scholar

  3. Bergeron N, Havel RJ. Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele. J Clin Invest. 1996 Jan 1;97(1):65-72.. PubMed | Google Scholar

  4. Wilson PF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia and coronary heart disease: the Framingham Offspring Study. JAMA. 1994; 272 (21): 1666-1671. PubMed | Google Scholar

  5. Tsai MS, Tangalos EG, Petersen RC, et al. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet. 1994; 54 (4): 643-649. PubMed | Google Scholar

  6. Rall Sc Jr, Weisgraber KH, Mahley RW. Human apoprotein E heterogeneity - Cysteine-arginine interchanges in the amino acid sequence of the apo E isoforms. J Biol Chem. 1981; 256(17): 9077-9083. PubMed | Google Scholar

  7. Vuorio AF, Turtola H, Piilahti KM, et al. Familial hypercholesterolemia in the Finnish north Karelia: a molecular, clinical, and genealogical study. Arterioscler Thromb Vasc Biol. 1997; 17(11):3127-3138. PubMed | Google Scholar

  8. Eto M, Watanabe K, Chonan N, et al. Familial hypercholesterolemia and apolipoprotein E4. Atheroscler. 1988; 72(2-3):123-12. PubMed | Google Scholar

  9. De Knijff P, Stalenhoef AF, Mol MJ, et al. Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia. Atheroscler. 1990; 83(1):89-97. PubMed | Google Scholar

  10. Kitahara M, Shinomiya M, Shirai K, et al. Frequency and role of apo E phenotype in familial hypercholesterolemia and non-familial hyperlipidemia in the Japanese. Atheroscler. 1990; 82(3):197- 204. PubMed | Google Scholar

  11. Hill JS, Hayden MR, Frohlich J, et al. Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia. Arterioscler Thromb. 1991; 11(2): 290-297. PubMed | Google Scholar

  12. Gylling H, Aalto-Setala K, Kontula K, et al. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia. Arterioscler Thromb. 1991; 11(5):1368-1375. PubMed | Google Scholar

  13. Kotze MJ, De Villiers WJ, Steyn K, et al. Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations. Arterioscler Thromb. 1993; 13(10):1460-1468. PubMed | Google Scholar

  14. Ferrieres J, Sing CF, Roy M, et al. Apolipoprotein E polymorphism and heterozygous familial hypercholesterolemia: sex-specific effects. Arterioscler Thromb. 1994; 14(10):1553-1560. PubMed | Google Scholar

  15. Lindahl G, Mailly F, Humphries S, et al. Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia: implication for lipoprotein(a) metabolism. Clin Invest Med. 1994; 72(18):631-638. PubMed | Google Scholar

  16. Tonstad S, Leren TP, Sivertsen M, et al. Determinants of lipid levels among children with heterozygous familial hypercholesterolemia in Norway. Arterioscler Thromb Vasc Biol. 1995; 15(8):1009-1014. PubMed | Google Scholar

  17. Betard C, Kessling AM, Roy M, et al. Influence of genetic variability in the nondeletion LDL-receptor allele on phenotypic variation in French-Canadian familial hypercholesterolemia heterozygotes sharing a "null" LDL-receptor gene defect. Atheroscler. 1996; 119(1):43-55. PubMed | Google Scholar

  18. Carmena-Ramon R, Real JT, Ascaso JF, et al. Effect of apolipoprotein E genotype on lipid levels and response to diet in familial hypercholesterolemia. Nutr Metab Cardiovasc Dis. 2000; 10(1):7-13. PubMed | Google Scholar

  19. Bertolini S, Cantafora A, Averna M, et al. Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype. Arterioscler Thromb Vasc Biol. 2000; 20(9):E41-52. PubMed | Google Scholar

  20. Lambert M, Assouline L, Feoli-Fonseca JC, et al. Determinants of lipid level variability in French-Canadian children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2001; 21(6):979-984. PubMed | Google Scholar

  21. Mozas P, Castillo S, Reyes G, et al: Spanish group FH. Apolipoprotein E genotype is not associated with cardiovascular disease in heterozygous subjects with familial hypercholesterolemia. Am Heart J. 2003; 145(6): 999-1005. PubMed | Google Scholar

  22. Miller SA, Dykes DO, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3): 1215. PubMed | Google Scholar

  23. Rozen S, Skaletsky HJ. Primer3 on the www for general users and for biologist programmers. In: Bioinformatics Methods and Protocols: Methods in Molecular Biology. Krawetz S, Misener S, eds. 2000. Humana Press. PubMed | Google Scholar

  24. Lahlali-Kacemi N, Bamou Y, Guedira A, Hassani M, Visvikis S, Siest G, Alami N, Kabbaj O, Lahrichi M. Polymorphisme de l'apolipoprotéine E dans une population marocaine: fréquence allélique et relation avec les paramètres lipidiques plasmatiques. Annal biol clin. 2002; 60(1): 73-78. PubMed | Google Scholar

  25. Valveny N, Esteban E, Kandil M, Moral P. Apo E polymorphism in Spanish and Moroccan populations. Clin Genet. 1997; 51(5): 354-356. PubMed | Google Scholar

  26. Harich N, Esteban E, Lopez-Alomar A, Chafik A, Moral P. Apolipoprotein molecular variation in Moroccan berbers: Pentanucleotide (TTTTA)n repeat in the LPA gene and APOE-C1-C2 gene cluster. Clin Genet. 2002; 62(3): 240-244. PubMed | Google Scholar

  27. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem. 1993; 39(10): 2125-2129. PubMed | Google Scholar

  28. Sheehan D, Bennett T, Cashman K. Apolipoprotein E gene polymorphisms and serum cholesterol in healthy Irish adults: a proposed genetic marker for coronary artery disease risk. Ir J Med Sci. 2000; 169(1): 50-54. PubMed | Google Scholar

  29. Ehnolm C, Lukka M, Nikkila E, Uterman G. Apolipoprotein E polymorphism in Finnish population: gene frequencies and relation to lipoproteins concentrations. J Lipid Res. 1986; 27(3): 227-235. PubMed | Google Scholar

  30. Benyahya F, Bennani M, Barakat A, Blesa S, et al. Identification of Four Novel LDL Receptor Gene Mutations in the North-West Moroccan Population. J Appl Res. 2010; 10(2): 68-72. PubMed | Google Scholar

  31. Jemaa R, Elasmi M, Naouali C, Feki M, Kallel A, Souissi M, Sanhaji H, Hadj Taïeb S, Souheil O, Kaabachi N. Apolipoprotein E polymorphism in the Tunisian population: Frequency and effect on lipid parameters. Clin Biochem. 2006; 39(8): 816-820. PubMed | Google Scholar

  32. Mediene-Benchekor S, Meroufel D, Brousseau T, Amouyel P, Benhamamouch S. Impact du polymorphisme apoe/hhai sur les lipides plasmatiques et liinfarctus du myocarde dans un échantillon de la population oranaise. JAM. 2004; 4: 173-176. PubMed | Google Scholar

  33. Bailleul S, Couderc R, Landais V, Lefevre G, Raichvarg D, Étienne J. Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France). Human Heredit. 1993; 43(3): 159-165. PubMed | Google Scholar

  34. Siest G, Visvikis S, Herbeth B, Gueguen R, Vincent-Viry M, Sass C. Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: the Stanislas cohort. Clin Chem Lab Med. 1998; 36(1): 35-42. PubMed | Google Scholar

  35. Adroer R, Santacruz P, Blesa R, Lopez-Pousa S, Ascaso C, Oliva R. Apolipoprotein E4 allele frequency in Spanish Alzheimer and control cases. Neurosci Lett. 1995; 189(3): 182-186. PubMed | Google Scholar

  36. Moral P, Valveny N, López-Alomar A, Calo C, Kandil M, Harich N, González-Pérez E, Via M, Esteban E, Dugoujon Jm, Vona G. Molecular variation at functional genes and the history of human populations--data on candidate genes for cardiovascular risk in the Mediterranean. Coll Antropol. 2003; 27(2):523-5. PubMed | Google Scholar

  37. Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele? Ann Hum Genet. 1999; 63(4):301-310. PubMed | Google Scholar

  38. Real JT, Ascaso JF, Chaves FJ, et al. Influence of plasma lipids, APOE genotype and type of LDL receptor gene mutations on myocardial infarction in subjects with familial hypercholesterolemia. Med Clin. 2002; 118: 681-685. PubMed | Google Scholar

  39. Vasilios G Athyros. Familial Hypercholesterolaemia in Greece. Hellenic J Cardiol. 2004; 45(8): 305-307. PubMed | Google Scholar

  40. Fumeron F, Rigaud D, Bertiere MC, Bardon S, Dely C, Apfelbaum M. Association of apolipoprotein µ 4 allele with hypertriglyceridemia in obesity. Clin Genet. 1988; 34(4): 258-264. PubMed | Google Scholar

  41. Gueguen R, Visvikis S, Steinmetz J, Siest G, Boerwinkle E. An analysis of genotype effects and their interactions by using the apolipoprotein E polymorphism and longitudinal data. Am J Hum Genet. 1989; 45(5): 702-793. PubMed | Google Scholar